Panmure Gordon & Co is pleased to announce its appointment as Nominated Adviser and broker to Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company"), the fully integrated specialty pharmaceutical company. Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.